Listen

Press releases

Receive e-mail alerts

Interne link ProQR Announces Year End 2025 Operating and Financial Results
maart 12, 2026 om 11:00 AM UTC
Interne link ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference
maart 03, 2026 om 09:30 PM UTC
Interne link ProQR Announces Planned Changes to Board Composition
februari 09, 2026 om 01:00 PM UTC
Interne link ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook
januari 08, 2026 om 01:00 PM UTC
Interne link ProQR Announces Results for the Third Quarter of 2016
november 14, 2016 om 12:00 PM UTC
Interne link ProQR Announces that QR-010 Meets the Primary Endpoint in a Proof of Concept Study of Homozygous F508del Cystic Fibrosis Patients
oktober 27, 2016 om 11:00 AM UTC
Interne link ProQR Announces Clinical Data Presentations and Investor & Analyst Event at NACFC
september 27, 2016 om 11:00 AM UTC
Interne link ProQR to Present at Scientific and Investor Conferences in September
september 06, 2016 om 11:00 AM UTC
Interne link ProQR Announces Results for the Second Quarter of 2016
augustus 17, 2016 om 11:00 AM UTC
Interne link ProQR Receives Fast Track Designation from FDA for QR-010 for Cystic Fibrosis
juli 19, 2016 om 11:00 AM UTC
Interne link ProQR to Release Topline Data from Proof of Concept Study of QR-010 in Cystic Fibrosis Patients at NACFC
juni 21, 2016 om 01:00 PM UTC
Interne link ProQR’s Drug Candidate QR-110 for Leber’s Congenital Amaurosis Type 10 Receives EMA and FDA Orphan Drug Designation
juni 01, 2016 om 11:00 AM UTC
Interne link ProQR Announces Presentations at the European CF Conference and the JMP Life Science Conference
juni 01, 2016 om 11:00 AM UTC
Interne link ProQR Announces Results for the First Quarter of 2016
mei 18, 2016 om 11:00 AM UTC
Interne link ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-110 for LCA10 at the 2016 ARVO Annual Meeting
april 25, 2016 om 08:00 PM UTC
Interne link ProQR Announces Annual Meeting of Shareholders
april 07, 2016 om 11:00 AM UTC
Interne link ProQR to Highlight a Growing Pipeline During a Research & Development Day and Present at the Barclays Global Healthcare Conference
maart 01, 2016 om 12:00 PM UTC
Interne link ProQR Announces Results for the Fourth Quarter and Full Year 2015
februari 17, 2016 om 12:00 PM UTC
Interne link ProQR to Present at the Leerink Partners Global Healthcare Conference
februari 03, 2016 om 12:00 PM UTC
Interne link ProQR Therapeutics Announces Results for the Third Quarter of 2014
november 24, 2014 om 12:00 PM UTC
Interne link ProQR Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
september 23, 2014 om 05:37 PM UTC
Interne link ProQR Announces Pricing of Initial Public Offering
september 18, 2014 om 12:07 PM UTC

Press releases

Interne link ProQR Announces Year End 2025 Operating and Financial Results

Interne link ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference

Interne link ProQR Announces Planned Changes to Board Composition

Interne link ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook

Interne link ProQR Announces Results for the Third Quarter of 2016

Interne link ProQR Announces that QR-010 Meets the Primary Endpoint in a Proof of Concept Study of Homozygous F508del Cystic Fibrosis Patients

Interne link ProQR Announces Clinical Data Presentations and Investor & Analyst Event at NACFC

Interne link ProQR to Present at Scientific and Investor Conferences in September

Interne link ProQR Announces Results for the Second Quarter of 2016

Interne link ProQR Receives Fast Track Designation from FDA for QR-010 for Cystic Fibrosis

Interne link ProQR to Release Topline Data from Proof of Concept Study of QR-010 in Cystic Fibrosis Patients at NACFC

Interne link ProQR’s Drug Candidate QR-110 for Leber’s Congenital Amaurosis Type 10 Receives EMA and FDA Orphan Drug Designation

Interne link ProQR Announces Presentations at the European CF Conference and the JMP Life Science Conference

Interne link ProQR Announces Results for the First Quarter of 2016

Interne link ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-110 for LCA10 at the 2016 ARVO Annual Meeting

Interne link ProQR Announces Annual Meeting of Shareholders

Interne link ProQR to Highlight a Growing Pipeline During a Research & Development Day and Present at the Barclays Global Healthcare Conference

Interne link ProQR Announces Results for the Fourth Quarter and Full Year 2015

Interne link ProQR to Present at the Leerink Partners Global Healthcare Conference

Interne link ProQR Therapeutics Announces Results for the Third Quarter of 2014

Interne link ProQR Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Interne link ProQR Announces Pricing of Initial Public Offering